Početna › Sarkom mekih tkiva › Utah
Kliničke studije za Sarkom mekih tkiva u državi Utah
6 studija za Sarkom mekih tkiva traži sudionike na lokacijama u državi Utah.
Gradovi u državi Utah
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- GSK Investigational Site, West Valley City
U tijeku regrutacijaFaza 1/2
Sve dobne skupine · Oba spola · Ažurirano 1. lis 2026. · NCT07602777Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05732831A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT06242470Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
- START Mountain Region, West Valley City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. svi 2026. · NCT06132503Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 30. tra 2026. · NCT05297734A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Primary Children's Hospital, Salt Lake City
U tijeku regrutacijaFaza 2
18 Months – 40 Years · Oba spola · Ažurirano 12. kol 2025. · NCT05135975Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.